Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
April 18, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
April 11, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the American Academy of Neurology
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery
April 02, 2024 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Fortuna to present at the Gold Forum Europe 2024 in Zürich, Switzerland
March 25, 2024 05:00 ET
|
Fortuna Silver Mines Inc.
VANCOUVER, British Columbia, March 25, 2024 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) is pleased to announce that it will be attending Gold Forum Europe 2024, which is...
Arbutus to Participate in Two Upcoming Investor Conferences
March 08, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., March 08, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s Disease
March 05, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
Data shows reduction of microglia activation and improvement in behavior in rodent models of Alzheimer’s disease (AD) and Parkinson’s disease (PD)Nasal anti-CD3 reduced hemorrhage and edema that...
ATN to Present at Sidoti Spring 2024 Small Cap Virtual Investor Conference on March 14, 2024
February 27, 2024 16:35 ET
|
ATN International, Inc.
BEVERLY, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- ATN International, Inc. (Nasdaq: ATNI), a leading provider of digital infrastructure and communications services, today announced that Chief...
mdf commerce annonce la date de la conférence téléphonique sur les résultats financiers du troisième trimestre de l'exercice 2024
January 30, 2024 08:00 ET
|
mdf commerce inc.
MONTRÉAL, 30 janv. 2024 (GLOBE NEWSWIRE) -- mdf commerce inc. (TSX:MDF), un leader des technologies de commerce électronique de type logiciel-service (« SaaS »), tiendra une conférence...
mdf commerce announces the date of the conference call for third quarter of fiscal year 2024 financial results
January 30, 2024 08:00 ET
|
mdf commerce inc.
MONTREAL, Jan. 30, 2024 (GLOBE NEWSWIRE) -- mdf commerce inc. (TSX: MDF), a SaaS leader in digital commerce technologies, will hold a conference call to discuss third quarter of fiscal year 2024...
Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024
January 05, 2024 09:30 ET
|
Tiziana Life Sciences Ltd.
Tiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024